Profile data is unavailable for this security.
About the company
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
- Revenue in USD (TTM)430.55m
- Net income in USD-21.49m
- Incorporated2001
- Employees1.02k
- LocationAccuray Inc1240 DEMING WAYMADISON 53717United StatesUSA
- Phone+1 (608) 824-2800
- Fax+1 (408) 716-4601
- Websitehttps://www.accuray.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KORU Medical Systems Inc | 29.32m | -13.27m | 102.05m | 82.00 | -- | 5.33 | -- | 3.48 | -0.2905 | -0.2905 | 0.6422 | 0.4181 | 0.8919 | 2.38 | 6.85 | 357,595.80 | -40.35 | -17.60 | -47.06 | -20.29 | 60.24 | 59.44 | -45.24 | -21.70 | 3.37 | -- | 0.0284 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| Fonar Corp | 102.72m | 10.29m | 103.77m | 561.00 | 10.44 | 0.6261 | 5.50 | 1.01 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
| Akoya Biosciences Inc | 93.57m | -68.01m | 112.85m | 330.00 | -- | 3.45 | -- | 1.21 | -1.47 | -1.47 | 1.99 | 0.6632 | 0.6056 | 2.20 | 7.08 | 283,554.50 | -44.01 | -- | -56.06 | -- | 55.99 | -- | -72.68 | -- | 2.38 | -10.15 | 0.7013 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Myomo Inc | 19.55m | -9.34m | 116.99m | 101.00 | -- | 10.72 | -- | 5.98 | -0.2676 | -0.2676 | 0.5775 | 0.3786 | 1.29 | 3.23 | 12.10 | 193,552.80 | -61.73 | -81.78 | -89.94 | -115.27 | 67.39 | 68.50 | -47.77 | -85.76 | 2.40 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Electromed Inc | 53.50m | 4.36m | 140.74m | 170.00 | 32.90 | 3.31 | 27.19 | 2.63 | 0.4942 | 0.4942 | 6.08 | 4.92 | 1.17 | 3.31 | 2.25 | 314,682.30 | 9.49 | 7.86 | 11.03 | 9.14 | 76.41 | 76.25 | 8.14 | 7.38 | 5.87 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| TELA Bio Inc | 63.15m | -40.30m | 147.44m | 227.00 | -- | 10.25 | -- | 2.33 | -1.67 | -1.67 | 2.61 | 0.5834 | 0.9668 | 1.37 | 7.60 | 278,180.60 | -61.70 | -52.00 | -79.77 | -60.95 | 68.97 | 65.32 | -63.82 | -107.65 | 3.23 | -8.52 | 0.7387 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| Accuray Inc | 430.55m | -21.49m | 151.84m | 1.02k | -- | 3.70 | -- | 0.3527 | -0.2197 | -0.2197 | 4.42 | 0.4139 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.3857 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| InfuSystem Holdings Inc | 127.41m | 84.00k | 152.47m | 499.00 | 2,575.54 | 2.92 | 12.40 | 1.20 | 0.0028 | 0.0028 | 5.91 | 2.46 | 1.23 | 10.66 | 6.57 | 255,330.70 | 0.0811 | 4.60 | 0.0955 | 5.69 | 50.27 | 56.43 | 0.0659 | 4.07 | 1.51 | 1.56 | 0.3641 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Akso Health Group - ADR | 2.20m | -17.07m | 158.42m | 12.00 | -- | -- | -- | 71.92 | -0.7466 | -0.2461 | 0.0963 | -- | 0.1166 | 1.91 | 0.3202 | 183,560.00 | -89.84 | -17.36 | -224.28 | -23.99 | 7.56 | -- | -770.59 | -256.64 | 1.36 | -24.02 | 0.6531 | -- | 119.69 | -34.25 | -221.68 | -- | -- | -- |
| Semler Scientific Inc | 65.88m | 21.69m | 164.99m | 92.00 | 8.40 | 2.07 | 7.39 | 2.50 | 2.78 | 2.78 | 8.45 | 11.26 | 0.855 | 15.13 | 8.51 | 716,097.80 | 28.14 | 38.83 | 31.14 | 44.41 | 89.43 | 90.22 | 32.92 | 32.58 | 12.11 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Clearpoint Neuro Inc | 26.16m | -20.63m | 166.17m | 107.00 | -- | 4.80 | -- | 6.35 | -0.8326 | -0.8326 | 1.05 | 1.26 | 0.5037 | 1.26 | 10.08 | 244,495.30 | -39.71 | -34.75 | -49.90 | -39.67 | 57.10 | 64.75 | -78.84 | -76.91 | 2.61 | -- | 0.2237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Stereotaxis Inc | 27.10m | -21.22m | 172.72m | 122.00 | -- | 11.78 | -- | 6.37 | -0.2575 | -0.2575 | 0.3288 | 0.2439 | 0.6012 | 1.45 | 6.14 | 222,155.70 | -44.08 | -25.02 | -63.05 | -34.12 | 55.16 | 67.57 | -73.32 | -41.90 | 1.79 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| CVRx Inc | 42.09m | -52.01m | 184.21m | 200.00 | -- | 2.78 | -- | 4.38 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 189.68m | 56.00 | -- | 3.32 | -- | 85.60 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Outset Medical Inc | 125.08m | -168.77m | 201.98m | 480.00 | -- | 2.17 | -- | 1.61 | -3.38 | -3.38 | 2.50 | 1.80 | 0.3529 | 1.82 | 3.53 | 260,577.10 | -47.61 | -41.40 | -54.98 | -47.29 | 24.61 | 5.71 | -134.93 | -159.05 | 5.32 | -32.13 | 0.6786 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
Data as of May 23 2024. Currency figures normalised to Accuray Inc's reporting currency: US Dollar USD
39.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.72m | 6.77% |
| Archon Capital Management LLCas of 31 Mar 2024 | 6.51m | 6.57% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 5.81m | 5.86% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 5.06m | 5.10% |
| Royce & Associates LPas of 31 Mar 2024 | 3.27m | 3.30% |
| Heartland Advisors, Inc.as of 31 Mar 2024 | 2.92m | 2.94% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 2.80m | 2.83% |
| Geode Capital Management LLCas of 31 Mar 2024 | 2.08m | 2.10% |
| Harbert Fund Advisors, Inc.as of 31 Mar 2024 | 1.85m | 1.87% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.81m | 1.82% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
